NHS adds Semaglutide to Its Weight Loss Treatment Options for Qualifying Patients
The UK’s National Health Service (NHS) has announced the addition of semaglutide to its weight loss treatment options for qualifying patients. Semaglutide is an injectable medication that is currently used to treat type 2 diabetes. Its efficacy in promoting weight loss has been demonstrated in clinical trials, and it has been approved by regulatory authorities […]
NHS adds Semaglutide to Its Weight Loss Treatment Options for Qualifying Patients Read More »